SCHEMBL29429653

SCHEMBL29429653

O=S(=O)(O)c1cc(O)c2cc(O)ccc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 3/20 0.70
NSD2 O96028 3/20 0.64
CASP6 P55212 4/20 0.59
DUSP3 P51452 2/20 0.59
PTPN5 P54829 2/20 0.59
PTPN11 Q06124 2/20 0.59
CASP7 P55210 1/20 0.59
HSD17B10 Q99714 5/20 0.54
CYP2C9 P11712 3/20 0.54
ALDH1A1 P00352 3/20 0.54
CYP2C19 P33261 2/20 0.54
PRMT1 Q99873 1/20 0.51
LMNA P02545 2/20 0.47
MPL P40238 2/20 0.44
CYP1A2 P05177 2/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
PTGES O14684 1/20 0.42
HIF1A Q16665 2/20 0.42
TSHR P16473 1/20 0.42
PTPRA P18433 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1413079 1.00 NT5E (0.70) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL1070221 1.00 NT5E (0.70) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL1070218 0.98 NT5E (0.68) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL21177815 0.92 NT5E (0.60) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL8109724 0.89 NT5E (0.74) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL10881561 0.85 NT5E (0.56) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL31255685 0.85 PTGES (0.52) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL3201337 0.85 CASP6 (0.70) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL18274862 0.85 PTGES (0.52) NT5ENSD2CASP6DUSP3PTPN5
SCHEMBL29364155 0.85 PTGES (0.52) NT5ENSD2CASP6DUSP3PTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333472-A1 Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto GEORGE MASON RES FOUNDATION INC (US) 2025-10-30 US disclosed
CN-119013434-A Electronic component 日本帕卡濑精株式会社 2024-11-22 CN disclosed
CN-118922172-A Hair cleansing composition 花王株式会社 2024-11-08 CN disclosed
CN-117946536-A Preparation process of gray black reactive dye 浙江劲光实业股份有限公司 2024-04-30 CN disclosed
CN-113811364-B Hair treatment method 花王株式会社 2023-09-05 CN disclosed
CN-110198702-B Hair treatment method 花王株式会社 2022-11-29 CN disclosed
CN-109388021-B Composition for forming organic film 信越化学工业株式会社 2022-09-27 CN disclosed
EP-3967371-A1 HAIR TREATMENT METHOD Kao Corporation (JP) 2022-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333472-A1 Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto SNRPE, SSBP1, RPA1 NT5E 2959/4885NSD2 4541/4885CASP6 3035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.